Beta Bionics
PublicBeta Bionics is now publicly traded
The data on this page reflects Beta Bionics's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Went Public
Jan 30, 2025
Last Round
Series E
Nov 13, 2024
Total Funding Raised
$548M
Company Overview
Beta Bionics is a healthcare technology company that develops a bionic pancreas device aimed at alleviating the challenges and expenses associated with diabetes management through an advanced dual-chamber infusion pump that autonomously delivers insulin and glucagon to help patients maintain optimal blood sugar levels.
Sector
Healthcare/Wellness
AI Layer
Application
Keywords
Beta Bionics Comparables
Compare Beta Bionics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PharmaSens AG | 62% | |
| Pocket Clinic Corp. | 57% | |
| Defymed | 42% | |
Beta Bionics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | Jan 30, 2025 | ||||
| Series E | Nov 13, 2024 | ||||
| Series D | Aug 30, 2023 | ||||
| Series C | Feb 17, 2022 | ||||
| Series B Extension | Jul 1, 2019 | ||||
Series B | Jan 8, 2019 |
Beta Bionics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Soleus Capital | Series D, Series E, Series C |
| Farallon Capital Management | Series B Extension, Series D, Series C |
| LifeSci Venture Partners | Series C, Series B |
| Omega Funds | Series E, Series D |
| Perceptive Advisors | Series D, Series E, Series B Extension, Series C |
| Eventide Funds | Series B Extension, Series D, Series E, Series C, Series B |
| BofA Securities | IPO |
Beta Bionics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
